Nymox Pharm Corp (NYMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NYMX | AMGN | VRTX | REGN | BMY |
| Company | Nymox Pharm Corp | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.2200 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 0.2200 | 279.50 | 406.95 | 913.00 | 44.47 |
| Low | 0.1827 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 0.2000 | 278.98 | 404.81 | 912.45 | 44.26 |
| Change | -0.0490 | +5.04 | +12.00 | +21.79 | +0.32 |
| % Change | -19.68% | +1.84% | +3.05% | +2.45% | +0.73% |
| Volume | 932,700 | 1,196,499 | 696,733 | 275,040 | 9,009,176 |
| 20-Day Average Volume | 309,280 | 2,182,108 | 968,629 | 459,513 | 13,835,650 |
| Previous Close | 0.2490 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3282 | 269.77 | 399.06 | 909.51 | 48.22 |
| 20-Day Raw Stochastic | 12.57% | 99.78% | 65.60% | 41.30% | 7.62% |
| 20-Day Relative Strength | 33.51% | 54.13% | 50.12% | 45.55% | 29.57% |
| Weighted Alpha | -62.47 | +15.46 | +15.98 | +18.52 | -35.92 |
| Today's Opinion | 56% Sell | 16% Sell | 8% Buy | 24% Buy | 88% Sell |
| Previous Opinion | 56% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 32% Buy | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -28.98% since 06/28/23 | +2.18% since 04/24/24 | +1.11% since 04/24/24 | +0.51% since 04/24/24 | -9.20% since 04/24/24 |
| Low | 0.1688 on 06/30/23 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.3500 on 07/03/23 | 279.00 on 05/01/24 | 405.72 on 05/01/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -50.94% since 06/06/23 | -1.44% since 04/01/24 | -3.63% since 04/01/24 | -6.00% since 04/01/24 | -16.28% since 04/01/24 |
| Low | 0.1688 on 06/30/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.4170 on 06/16/23 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | -43.80% since 04/06/23 | -14.05% since 02/01/24 | -6.61% since 02/01/24 | -4.87% since 02/01/24 | -8.85% since 02/01/24 |
| Low | 0.1688 on 06/30/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.4950 on 05/08/23 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -50.73% since 01/06/23 | +6.95% since 11/01/23 | +9.71% since 11/01/23 | +15.15% since 11/01/23 | -13.48% since 11/01/23 |
| Low | 0.1688 on 06/30/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 0.5299 on 02/16/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,103 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 90,515 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -6,580,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,390,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.64 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 05/12/23 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 08/21/23 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |